Anna Wancerz

549 total citations
11 papers, 97 citations indexed

About

Anna Wancerz is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Surgery. According to data from OpenAlex, Anna Wancerz has authored 11 papers receiving a total of 97 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 2 papers in Immunology and 1 paper in Surgery. Recurrent topics in Anna Wancerz's work include Atrial Fibrillation Management and Outcomes (5 papers), Cardiac pacing and defibrillation studies (3 papers) and Cardiac Arrhythmias and Treatments (3 papers). Anna Wancerz is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Cardiac pacing and defibrillation studies (3 papers) and Cardiac Arrhythmias and Treatments (3 papers). Anna Wancerz collaborates with scholars based in Poland, Spain and Italy. Anna Wancerz's co-authors include Grzegorz Opolski, Agnieszka Kapłon‐Cieślicka, Agata Tymińska, Paweł Balsam, Krzysztof Ozierański, Krzysztof J. Filipiak‬, Michał Peller, María G. Crespo‐Leiro, Marcin Grabowski and Aldo P. Maggioni and has published in prestigious journals such as European Heart Journal, International Journal of Clinical Practice and Biology.

In The Last Decade

Anna Wancerz

11 papers receiving 93 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Wancerz Poland 5 69 24 22 12 11 11 97
Nabeel Ahmed United Kingdom 4 50 0.7× 23 1.0× 19 0.9× 5 0.4× 12 1.1× 8 97
Adriana Saltijeral Cerezo Spain 5 39 0.6× 10 0.4× 71 3.2× 30 2.5× 8 0.7× 7 100
Ewa Pilichowska‐Paszkiet Poland 9 183 2.7× 22 0.9× 20 0.9× 4 0.3× 15 1.4× 16 222
Hiroshi Fukunaga Japan 7 66 1.0× 7 0.3× 32 1.5× 4 0.3× 7 0.6× 20 103
Aurelia Grosu Italy 7 117 1.7× 6 0.3× 19 0.9× 6 0.5× 10 0.9× 20 151
Eduardo Chuquiure‐Valenzuela Mexico 4 32 0.5× 13 0.5× 17 0.8× 2 0.2× 12 1.1× 17 59
Ursula‐Henrike Wienhues‐Thelen Germany 6 70 1.0× 5 0.2× 11 0.5× 4 0.3× 16 1.5× 8 102
Patricia Rubio Spain 4 15 0.2× 10 0.4× 59 2.7× 11 0.9× 6 0.5× 6 76
Teresa D'Amico Italy 6 46 0.7× 13 0.5× 17 0.8× 6 0.5× 4 0.4× 13 79
Hirotoshi Ichibori Japan 6 95 1.4× 13 0.5× 24 1.1× 2 0.2× 7 0.6× 14 114

Countries citing papers authored by Anna Wancerz

Since Specialization
Citations

This map shows the geographic impact of Anna Wancerz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Wancerz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Wancerz more than expected).

Fields of papers citing papers by Anna Wancerz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Wancerz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Wancerz. The network helps show where Anna Wancerz may publish in the future.

Co-authorship network of co-authors of Anna Wancerz

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Wancerz. A scholar is included among the top collaborators of Anna Wancerz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Wancerz. Anna Wancerz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Budnik, Monika, Monika Gawałko, Piotr Lodziński, et al.. (2022). Heart Failure in Patients with Atrial Fibrillation: Insights from Polish part of the EORP-AF General Long-Term Registry. ESC Heart Failure. 10(1). 637–649. 3 indexed citations
3.
Gawałko, Monika, Piotr Lodziński, Monika Budnik, et al.. (2020). Vascular disease in patients with atrial fibrillation. A report from Polish participants in the EORP‐AF General Long‐Term Registry. International Journal of Clinical Practice. 75(3). e13701–e13701. 3 indexed citations
4.
Tymińska, Agata, Agnieszka Kapłon‐Cieślicka, Krzysztof Ozierański, et al.. (2019). Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction. Disease Markers. 2019. 1–12. 15 indexed citations
5.
Tymińska, Agata, Agnieszka Kapłon‐Cieślicka, Krzysztof Ozierański, et al.. (2019). Association of galectin-3 and soluble ST2 with in-hospital and one-year outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Polskie Archiwum Medycyny Wewnętrznej. 129(11). 770–780. 16 indexed citations
6.
Ozierański, Krzysztof, Paweł Balsam, Agnieszka Kapłon‐Cieślicka, et al.. (2019). Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology. Cardiovascular Drugs and Therapy. 33(1). 77–86. 14 indexed citations
7.
8.
Ozierański, Krzysztof, Agnieszka Kapłon‐Cieślicka, Paweł Balsam, et al.. (2018). Do β-blockers improve one-year survival in heart failure patients with atrial fibrillation? Results from the ESC-HF Registry. Polskie Archiwum Medycyny Wewnętrznej. 128(11). 649–657. 7 indexed citations
9.
Tymińska, Agata, Paweł Balsam, Krzysztof Ozierański, et al.. (2017). Heart failure patients with a previous coronary revascularization: results from the ESC-HF Registry. Kardiologia Polska. 76(1). 144–152. 4 indexed citations
10.
Tymińska, Agata, Paweł Balsam, Krzysztof Ozierański, et al.. (2017). P5821Ischemic versus dilated cardiomyopathy - differences in clinical characteristics and prognosis depending on heart failure etiology. European Heart Journal. 38(suppl_1). 1 indexed citations
11.
Ozierański, Krzysztof, Paweł Balsam, Agata Tymińska, et al.. (2017). P4899Do beta-blockers improve one-year survival in heart failure patients with atrial fibrillation? Results from the ESC-HF Registry. European Heart Journal. 38(suppl_1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nabeel Ahmed Breakdown of academic impact, for papers by Adriana Saltijeral Cerezo Breakdown of academic impact, for papers by Ewa Pilichowska‐Paszkiet Breakdown of academic impact, for papers by Hiroshi Fukunaga Breakdown of academic impact, for papers by Aurelia Grosu Breakdown of academic impact, for papers by Eduardo Chuquiure‐Valenzuela Breakdown of academic impact, for papers by Ursula‐Henrike Wienhues‐Thelen Breakdown of academic impact, for papers by Patricia Rubio Breakdown of academic impact, for papers by Teresa D'Amico Breakdown of academic impact, for papers by Hirotoshi Ichibori
Rankless by CCL
2026